NGI-1, a reversible catalytic subunit inhibitor of the OST, has higher specificity for STT3B than for STT3A.26 Since EREG acts as a key driver of oncogenesis and survival signaling in HNSCC, we asked the biochemical consequences of OST inhibition on EREG function. Here, EREG is linked to head and neck squamous cell carcinoma.